We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.18%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$325B
AUM Growth
-$10.8B
(-3.2%)
Cap. Flow
-$13.4B
Cap. Flow
% of AUM
-4.12%
Top 10 Holdings %
Top 10 Hldgs %
22.35%
Holding
3,492
New
145
Increased
887
Reduced
2,282
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$899M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$895M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$597M |
| 4 |
Clarivate
CLVT
|
+$315M |
| 5 |
Mastercard
MA
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.03B |
| 2 |
Apple
AAPL
|
+$962M |
| 3 |
Intel
INTC
|
+$470M |
| 4 |
Microsoft
MSFT
|
+$449M |
| 5 |
Home Depot
HD
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.56% |
| 2 | Financials | 13.11% |
| 3 | Healthcare | 12.33% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFI
3001
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $900K | ﹤0.01% |
247,910
-5,882
| -2% | -$18.1K |
|
|
ITIC
3002
Investors Title Co
ITIC
$547M
| $899K | ﹤0.01% |
4,913
-885
| -15% | -$159K |
|
3003
Vor Biopharma
VOR
$1.28B
| $899K | ﹤0.01% |
2,926
+516
| +21% | +$153K |
|
|
BRT
3004
BRT Apartments
BRT
$271M
| $891K | ﹤0.01% |
46,300
-2,200
| -5% | -$40.7K |
|
|
USX
3005
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $891K | ﹤0.01% |
103,812
+7,099
| +7% | +$61.6K |
|
3006
Gaotu Techedu
GOTU
$436M
| $888K | ﹤0.01% |
288,995
+127,117
| +79% | +$641K |
|
|
CS
3007
DELISTED
Credit Suisse Group
CS
| $885K | ﹤0.01% |
89,720
-5,065
| -5% | -$51.8K |
|
3008
Laird Superfood
LSF
$47.8M
| $883K | ﹤0.01% |
46,283
+5,149
| +13% | +$118K |
|
|
PZN
3009
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $878K | ﹤0.01% |
90,773
-1,049
| -1% | -$11.2K |
|
3010
ClearPoint Neuro
CLPT
$433M
| $874K | ﹤0.01% |
44,545
| – | – |
|
3011
Black Diamond Therapeutics
BDTX
$112M
| $873K | ﹤0.01% |
91,877
+1,230
| +1% | +$12.1K |
|
|
BLFY
3012
DELISTED
Blue Foundry Bancorp
BLFY
| $872K | ﹤0.01% |
+63,241
| New | +$849K |
|
3013
Flexsteel Industries
FLXS
$311M
| $872K | ﹤0.01% |
23,827
-231
| -1% | -$8.23K |
|
3014
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $868K | ﹤0.01% |
32,781
-491
| -1% | -$13.1K |
|
3015
Coastal Financial
CCB
$693M
| $867K | ﹤0.01% |
27,592
-1,694
| -6% | -$50.5K |
|
|
SURF
3016
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $867K | ﹤0.01% |
122,099
+22,983
| +23% | +$147K |
|
3017
Lifetime Brands
LCUT
$211M
| $866K | ﹤0.01% |
49,970
-3,438
| -6% | -$57.5K |
|
|
DZSI
3018
DELISTED
DZS Inc. Common Stock
DZSI
| $864K | ﹤0.01% |
64,953
-1,341
| -2% | -$21.1K |
|
|
PSTX
3019
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $862K | ﹤0.01% |
107,684
+8,288
| +8% | +$71.1K |
|
3020
MaxCyte
MXCT
$126M
| $858K | ﹤0.01% |
+70,232
| New | +$1.06M |
|
3021
Daktronics
DAKT
$1.04B
| $854K | ﹤0.01% |
158,133
-3,213
| -2% | -$19.1K |
|
3022
Bridgford Foods
BRID
$56.5M
| $849K | ﹤0.01% |
70,834
| – | – |
|
3023
Universal Logistics Holdings
ULH
$529M
| $847K | ﹤0.01% |
43,312
-16,167
| -27% | -$350K |
|
|
EVLO
3024
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $847K | ﹤0.01% |
5,077
-343
| -6% | -$68K |
|
3025
Teekay
TK
$985M
| $846K | ﹤0.01% |
256,387
+3,063
| +1% | +$9.64K |
|
Similar funds
VFT
Nuveen's Q3 2021 Portfolio in Review
As of Q3 2021, Nuveen held 3,492 positions worth $325B, down 3.2% from $335B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen withdrew a net $13.4B in Q3 2021, closing 80 positions and reducing 2,282 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $219M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Nuveen opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $596M.
- Nuveen's largest Q3 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 6,810,000 shares worth $596M.
- Nuveen added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2021, an estimated $899M increase.
- Nuveen's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $1.03B.
- Nuveen fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $219M.
- Nuveen's ten largest holdings make up 22% of its $325B portfolio in Q3 2021.
- Nuveen opened 145 new positions and closed 80 in Q3 2021.
- Nuveen's portfolio value fell 3.2% quarter-over-quarter to $325B.
Based on Nuveen's 13F filing for Q3 2021, filed 12 Nov 2021.